Format
Sort by
Items per page

Send to

Choose Destination

Best matches for retinal vein occlusion:

[Retinal vein occlusions]. Pierru A et al. J Fr Ophtalmol. (2017)

Retinal Vein Occlusions. Jonas JB et al. Dev Ophthalmol. (2017)

RANIBIZUMAB FOR RETINAL VEIN OCCLUSION: Predictive Factors and Long-Term Outcomes in Real-Life Data. Chatziralli I et al. Retina. (2018)

Search results

Items: 1 to 50 of 5717

1.

ACUTE MACULAR AND PERIPAPILLARY ANGIOGRAPHIC CHANGES WITH INTRAVITREAL INJECTIONS.

Barash A, Chui TYP, Garcia P, Rosen RB.

Retina. 2019 Feb 11. doi: 10.1097/IAE.0000000000002433. [Epub ahead of print]

PMID:
30762649
2.

Branch retinal vein occlusion associated with platelet activation

Beyazyıldız E, Çıtırık M, Şimşek M, Beyazyıldız Ö, Haznedaroğlu İC.

Turk J Med Sci. 2019 Feb 11;49(1):283-287. doi: 10.3906/sag-1807-223.

PMID:
30761872
3.

Central Retinal Vein Occlusion Revealing Coeliac Disease.

Zoubeidi H, Ben Salem T, Ben Ghorbel I, Houman MH.

Eur J Case Rep Intern Med. 2016 Sep 20;3(7):000492. doi: 10.12890/2016_000492. eCollection 2016.

PMID:
30755896
4.

Papillophlebitis as manifestation of polyarteritis nodosa.

Rodríguez-González F, Reyes-Rodríguez M, Francisco-Hernández F, García-García Ú, Martínez-Quintana E.

Arch Soc Esp Oftalmol. 2019 Feb 4. pii: S0365-6691(19)30023-1. doi: 10.1016/j.oftal.2018.12.007. [Epub ahead of print] English, Spanish.

PMID:
30733066
5.

Early-scatter laser photocoagulation promotes the formation of collateral vessels in branch retinal vein occlusion.

An SH, Jeong WJ.

Eur J Ophthalmol. 2019 Feb 5:1120672119827857. doi: 10.1177/1120672119827857. [Epub ahead of print]

PMID:
30722692
6.

Microvascular Retinal and Choroidal Changes in Retinal Vein Occlusion Analyzed by Two Different Optical Coherence Tomography Angiography Devices.

Costanzo E, Parravano M, Gilardi M, Cavalleri M, Sacconi R, Aragona E, Varano M, Bandello F, Querques G.

Ophthalmologica. 2019 Feb 5:1-8. doi: 10.1159/000496195. [Epub ahead of print]

PMID:
30721901
7.

Macular Branch Retinal Vein Occlusion as a Rare Complication of Periocular Scorpion Bite: A Case Report and Literature Review.

Hamid A, Shirvani M, Maalhagh M, Rasti A.

Bull Emerg Trauma. 2019 Jan;7(1):76-79. doi: 10.29252/beat-0701012. No abstract available.

8.

Optical coherence tomography angiography findings in Behcet patients.

Emre S, Güven-Yılmaz S, Ulusoy MO, Ateş H.

Int Ophthalmol. 2019 Feb 1. doi: 10.1007/s10792-019-01080-1. [Epub ahead of print]

PMID:
30710254
9.

Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion.

Călugăru D, Călugăru M.

Surv Ophthalmol. 2019 Jan 28. pii: S0039-6257(18)30328-X. doi: 10.1016/j.survophthal.2019.01.006. [Epub ahead of print] No abstract available.

PMID:
30703403
10.

Suprachoroidally injected pharmacological agents for the treatment of chorio-retinal diseases: a targeted approach.

Habot-Wilner Z, Noronha G, Wykoff CC.

Acta Ophthalmol. 2019 Jan 31. doi: 10.1111/aos.14042. [Epub ahead of print] Review.

PMID:
30702218
11.

The Nd:YAG laser as first-line treatment for fibrin pupillary-block glaucoma following uncomplicated cataract surgery.

Khan S, Elashry M.

Oxf Med Case Reports. 2019 Jan 24;2019(1):omy113. doi: 10.1093/omcr/omy113. eCollection 2019 Jan.

12.

Understanding quality of life impact in people with retinal vein occlusion: a qualitative inquiry.

Prem Senthil M, Khadka J, Gilhotra JS, Simon S, Fenwick EK, Lamoureux E, Pesudovs K.

Clin Exp Optom. 2019 Jan 29. doi: 10.1111/cxo.12875. [Epub ahead of print]

PMID:
30695815
13.

Incidence of Open-angle Glaucoma in Newly Diagnosed Retinal Vein Occlusion: A Nationwide Population-based Study.

Na KI, Jeoung JW, Kim YK, Lee WJ, Park KH.

J Glaucoma. 2019 Feb;28(2):111-118. doi: 10.1097/IJG.0000000000001134.

PMID:
30689606
14.

Quantity and quality of image artifacts in optical coherence tomography angiography.

Enders C, Lang GE, Dreyhaupt J, Loidl M, Lang GK, Werner JU.

PLoS One. 2019 Jan 25;14(1):e0210505. doi: 10.1371/journal.pone.0210505. eCollection 2019.

15.

OCULAR ADVERSE EVENTS ASSOCIATED WITH MEK INHIBITORS.

Méndez-Martínez S, Calvo P, Ruiz-Moreno O, Pardiñas Barón N, Leciñena Bueno J, Gil Ruiz MDR, Pablo L.

Retina. 2019 Jan 23. doi: 10.1097/IAE.0000000000002451. [Epub ahead of print]

PMID:
30681641
16.

Short-term effect of intravitreal conbercept injection on major and macular branch retinal vein occlusion.

Tao Y, Huang C, Liu M, Sun L, Li L, Wei Y, Yu X, Wang H.

J Int Med Res. 2019 Jan 25:300060518819613. doi: 10.1177/0300060518819613. [Epub ahead of print]

PMID:
30678515
17.

CORRELATION OF EN FACE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AVERAGING VERSUS SINGLE-IMAGE QUANTITATIVE MEASUREMENTS WITH RETINAL VEIN OCCLUSION VISUAL OUTCOMES.

Jung JJ, Chen MH, Shi Y, Nassisi M, Marion K, Sadda SR, Hoang QV.

Retina. 2019 Jan 22. doi: 10.1097/IAE.0000000000002453. [Epub ahead of print]

PMID:
30676529
18.

Successful Total Resection of an Orbital Epithelioid Hemangioendothelioma with the Aid of Endovascular Embolization.

Jamshidian-Tehrani M, Eshraghi B, Zarei M, Nozarian Z, Rafizadeh SM, Ghadimi H.

Ocul Oncol Pathol. 2019 Jan;5(1):50-53. doi: 10.1159/000489126. Epub 2018 May 30.

PMID:
30675477
19.

Comment on: Bilateral combined central retinal artery and vein occlusion in a 3-year-old child with nephrotic syndrome.

Dwivedi A, Lakhtakia S.

Indian J Ophthalmol. 2019 Feb;67(2):312-313. doi: 10.4103/ijo.IJO_1633_18. No abstract available.

20.

A complication of ischemic branch retinal vein occlusion.

Ranjith PC, Giridhar A.

Indian J Ophthalmol. 2019 Feb;67(2):276. doi: 10.4103/ijo.IJO_882_18. No abstract available.

21.

A rare case having hemi-retinal artery occlusion in one eye and hemi-retinal vein occlusion in the other: Diverse manifestations of retinal vascular occlusion.

Agarwal P, Agarwal V, Azad S.

Indian J Ophthalmol. 2019 Feb;67(2):273-274. doi: 10.4103/ijo.IJO_987_18. No abstract available.

22.

Dexamethasone implant for immunogammopathy maculopathy associated with IgA multiple myeloma.

Georgakopoulos CD, Plotas P, Angelakis A, Kagkelaris K, Tzouvara E, Makri OE.

Ther Adv Ophthalmol. 2019 Jan 8;11:2515841418820441. doi: 10.1177/2515841418820441. eCollection 2019 Jan-Dec.

23.

Intravitreal corticosteroid implant vs intravitreal ranibizumab for the treatment of macular edema: a meta-analysis of randomized controlled trials.

Wei Q, Chen R, Lou Q, Yu J.

Drug Des Devel Ther. 2019 Jan 11;13:301-307. doi: 10.2147/DDDT.S184520. eCollection 2019.

24.

Bilateral simultaneous central retinal vein occlusion revealing Waldenström's macroglobulinemia.

Kammoun S, Kilani W, Abid F, Ben Amor S, Feki J.

Presse Med. 2019 Jan 18. pii: S0755-4982(18)30450-0. doi: 10.1016/j.lpm.2018.11.004. [Epub ahead of print] No abstract available.

PMID:
30665794
25.

AQUEOUS HUMOR CYTOKINES AND THERAPEUTIC CUSTOMIZATION IN NONRESPONDING MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION.

Modi A, Sharma K, Sudhakar NP, Yadav NK.

Retin Cases Brief Rep. 2019 Jan 17. doi: 10.1097/ICB.0000000000000768. [Epub ahead of print]

PMID:
30664079
26.

Deep-learning classifier with ultrawide-field fundus ophthalmoscopy for detecting branch retinal vein occlusion.

Nagasato D, Tabuchi H, Ohsugi H, Masumoto H, Enno H, Ishitobi N, Sonobe T, Kameoka M, Niki M, Mitamura Y.

Int J Ophthalmol. 2019 Jan 18;12(1):94-99. doi: 10.18240/ijo.2019.01.15. eCollection 2019.

27.

Development of a Novel Model of Central Retinal Vascular Occlusion and the Therapeutic Potential of the Adrenomedullin-Receptor Activity-Modifying Protein 2 System.

Hirabayashi K, Tanaka M, Imai A, Toriyama Y, Iesato Y, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Tanaka M, Dai K, Cui N, Wei Y, Nakamura K, Iida S, Matsui S, Yamauchi A, Murata T, Shindo T.

Am J Pathol. 2019 Feb;189(2):449-466. doi: 10.1016/j.ajpath.2018.10.021. Epub 2019 Jan 15.

PMID:
30658846
28.

Efficacy of panretinal laser in ischemic central retinal vein occlusion: A systematic review.

Li C, Wang R, Liu G, Ge Z, Jin D, Ma Y, Liu G.

Exp Ther Med. 2019 Jan;17(1):901-910. doi: 10.3892/etm.2018.7034. Epub 2018 Nov 29.

29.

Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab.

Onda M, Niimi Y, Ozawa K, Shiraki I, Mochizuki K, Yamamoto T, Sugita S, Ishida K.

BMC Ophthalmol. 2019 Jan 16;19(1):19. doi: 10.1186/s12886-019-1032-2.

30.

Long-term management of non-ischemic central retinal vein occlusion with fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN®).

Coelho J, Pessoa B, Meireles A.

Ther Adv Ophthalmol. 2019 Jan 5;11:2515841418820755. doi: 10.1177/2515841418820755. eCollection 2019 Jan-Dec.

31.

Functional and morphologic study of retinal hypoperfusion injury induced by bilateral common carotid artery occlusion in rats.

Qin Y, Ji M, Deng T, Luo D, Zi Y, Pan L, Wang Z, Jin M.

Sci Rep. 2019 Jan 14;9(1):80. doi: 10.1038/s41598-018-36400-5.

32.

OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.

Tang F, Qin X, Lu J, Song P, Li M, Ma X.

Retina. 2019 Jan 10. doi: 10.1097/IAE.0000000000002444. [Epub ahead of print]

PMID:
30640282
33.

Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion.

Lloyd Clark W, Liu M, Kitchens J, Wang PW, Haskova Z.

BMC Ophthalmol. 2019 Jan 8;19(1):11. doi: 10.1186/s12886-018-1012-y.

34.

Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis.

Gao L, Zhou L, Tian C, Li N, Shao W, Peng X, Shi Q.

BMC Ophthalmol. 2019 Jan 8;19(1):8. doi: 10.1186/s12886-018-1016-7.

35.

Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study.

Callizo J, Atili A, Striebe NA, Bemme S, Feltgen N, Hoerauf H, Bertelmann T.

Graefes Arch Clin Exp Ophthalmol. 2019 Jan 4. doi: 10.1007/s00417-018-04223-9. [Epub ahead of print]

PMID:
30610424
36.

Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world.

Zarranz-Ventura J, Sala-Puigdollers A, Velazquez-Villoria D, Figueras-Roca M, Copete S, Distefano L, Boixadera A, García-Arumi J, Adan A; Hospital Clínic—Hospital Vall de Hebron Intravitreal Dexamethasone Implant study group.

PLoS One. 2019 Jan 4;14(1):e0209997. doi: 10.1371/journal.pone.0209997. eCollection 2019.

37.

Quantitative measurement of vascular density and flow using optical coherence tomography angiography (OCTA) in patients with central retinal vein occlusion: Can OCTA help in distinguishing ischemic from non-ischemic type?

Khodabandeh A, Shahraki K, Roohipoor R, Riazi-Esfahani H, Yaseri M, Faghihi H, Bazvand F.

Int J Retina Vitreous. 2018 Dec 27;4:47. doi: 10.1186/s40942-018-0152-9. eCollection 2018.

38.

Rapid progression of cataract to mature stage after intravitreal dexamethasone implant injection: a case report.

Lee JH, Park JY, Kim JS, Hwang JH.

BMC Ophthalmol. 2019 Jan 3;19(1):1. doi: 10.1186/s12886-018-1008-7.

39.

[Subconjunctival Ozurdex® injection in branch retinal vein occlusion].

Sampo M, Nadeau S, Denis D, Matonti F.

J Fr Ophtalmol. 2019 Jan;42(1):89-91. doi: 10.1016/j.jfo.2018.03.030. Epub 2018 Dec 26. French. No abstract available.

PMID:
30594421
40.

Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion.

Qian T, Zhao M, Wan Y, Li M, Xu X.

BMJ Open. 2018 Dec 28;8(12):e022700. doi: 10.1136/bmjopen-2018-022700.

41.

Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes with Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study.

Ip MS, Oden NL, Scott IU, VanVeldhuisen PC, Blodi BA, Ghuman T, Baker CW; SCORE2 Investigator Group.

JAMA Ophthalmol. 2018 Dec 27. doi: 10.1001/jamaophthalmol.2018.6111. [Epub ahead of print]

PMID:
30589922
42.

Treatment controversies in a rare case of a simultaneous branch retinal artery and vein occlusion secondary to hyperhomocysteinemia and hypertension.

Christodoulou P, Katsimpris I.

Int J Ophthalmol. 2018 Dec 18;11(12):2024-2026. doi: 10.18240/ijo.2018.12.25. eCollection 2018. No abstract available.

43.

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis.

Tufail A, Lightman S, Kamal A, Pleyer U, Paniagua NMG, Dot C, Li XY, Jiao J, Lou J, Hashad Y; CONSTANCE Study Group.

Clin Ophthalmol. 2018 Dec 6;12:2519-2534. doi: 10.2147/OPTH.S181256. eCollection 2018.

44.

Acute Onset of Exogenous Endophthalmitis after Dexamethasone Implant Injection Treated without Implant Removal.

Bastakis GG, Stavrakakis A, Nikolaos A, Dimopoulos D, Pappas G.

Case Rep Ophthalmol Med. 2018 Nov 18;2018:4614802. doi: 10.1155/2018/4614802. eCollection 2018.

45.

Unilateral central retinal vein occlusion as a first manifestation of diabetes mellitus in a ten-year-old girl.

Alduaij AA, Alhamad D, Schatz P.

Saudi J Ophthalmol. 2018 Oct-Dec;32(4):346-348. doi: 10.1016/j.sjopt.2018.02.009. Epub 2018 Feb 27.

46.

Intravitreal bevacizumab upregulates transthyretin in experimental branch retinal vein occlusion.

Cehofski LJ, Kruse A, Alsing AN, Nielsen JE, Pedersen S, Kirkeby S, Honoré B, Vorum H.

Mol Vis. 2018 Nov 26;24:759-766. eCollection 2018.

47.

Branch Retinal Vein Occlusion (BRVO).

Cochran ML, Czyz CN.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Dec 19.

48.

[Foveal avascular zone and OCT angiography. An overview of current knowledge].

Mihailovic N, Eter N, Alnawaiseh M.

Ophthalmologe. 2018 Dec 19. doi: 10.1007/s00347-018-0838-2. [Epub ahead of print] Review. German.

PMID:
30569234
49.

Incomplete scleral penetration of dexamethasone (Ozurdex) intravitreal implant.

Sherman T, Raman V.

BMJ Case Rep. 2018 Dec 13;11(1). pii: e227055. doi: 10.1136/bcr-2018-227055.

PMID:
30567246
50.

Short-Term Assessment of Intravitreal Dexamethasone Implant Using Enhanced-Depth Image Optical Coherence Tomography and Optical Coherence Tomography Angiography in Patients with Retinal Vascular Diseases.

Minnella AM, Federici M, Pagliei V, Lanza A, Gambini G, Caputo CG, Falsini B, Caporossi A.

Adv Ther. 2019 Feb;36(2):416-425. doi: 10.1007/s12325-018-0848-0. Epub 2018 Dec 18.

PMID:
30565180

Supplemental Content

Loading ...
Support Center